Advancing the frontier of medicine
Pioneering Treatments for a Healthier World
Sonoma Pharmaceuticals develops innovative therapeutics targeting unmet medical needs — from dermatology to infectious disease.
Featured products
Targeted Therapies, Proven Results
Our portfolio addresses critical conditions with clinically validated, science-driven solutions.
Microcyn Technology
Proprietary super-oxidized solution platform with broad-spectrum antimicrobial activity for chronic and acute wound management.
NovaBay NeutroPhase
Next-generation wound irrigation solution targeting resistant biofilm-forming pathogens in complex dermatological conditions.
SonoVir-X
Novel antiviral compound leveraging oxidative chemistry to disrupt viral replication cycles across multiple pathogen classes.
Clinical pipeline
A Robust Pipeline Across Multiple Indications
Our diversified pipeline spans wound care, dermatology, and infectious disease — with multiple programs advancing through clinical development.
Why Sonoma
Built on Science. Driven by Purpose.
Proprietary Platform Technology
Our Microcyn platform is a foundational technology enabling multiple product lines across therapeutic areas — a durable competitive moat built over two decades of R&D.
Global Commercial Reach
Established distribution in 50+ countries with regulatory approvals across major markets including the US, EU, and Asia Pacific.
Clinically Validated
Every product backed by rigorous clinical evidence — peer-reviewed publications, randomized controlled trials, and real-world outcomes data.
Partner with us
Advancing Science Together
We collaborate with healthcare systems, distributors, and research institutions to bring breakthrough therapies to patients worldwide.